Source |
Groups |
Number of participants |
Dose of drug |
Surgical procedure |
Anjum et al. (2019) [12] |
D |
30 |
Inj. dexmedetomidine 1 µg/kg IV |
Elective neurosurgical procedures |
F |
30 |
Inj. fentanyl 2 µg/kg iv |
Arif et al. (2017) [13] |
D |
24 |
Inj. dexmedetomidine 0.75 µg/kg IV |
Elective surgical procedure |
F |
24 |
Inj. fentanyl 2 µg/kg IV |
Garg et al. (2020) [14] |
D |
50 |
Inj. dexmedetomidine 1 µg/kg IV |
Elective surgical procedure |
F |
50 |
Inj. fentanyl 2 µg/kg IV |
Gauchan et al. (2019) [15] |
D |
30 |
Inj. dexmedetomidine 1 µg/kg IV |
Elective surgical procedure |
F |
30 |
Inj. fentanyl 2 µg/kg IV |
Gunalan et al. (2015) [16] |
D |
30 |
Inj. dexmedetomidine 1 µg/kg IV |
Elective surgical procedure |
F |
30 |
Inj. fentanyl 2 µg/kg IV |
Mahiswar et al. (2022) [17] |
D |
50 |
Inj. dexmedetomidine 0.5 µg/kg IV |
Elective surgical procedure |
F |
50 |
Inj. fentanyl 2 µg/kg IV |
Mahjoubifard et al. (2020) [18] |
D |
30 |
Inj. dexmedetomidine 1 µg/kg IV |
Elective cardiac surgery |
F |
30 |
Inj. fentanyl 2 µg/kg IV |
Vaswani et al. (2017) [11] |
L |
30 |
1.5 mg/kg intravenous lidocaine |
D |
30 |
Inj. dexmedetomidine 0.5 µg/kg IV |
Elective laparotomy |
F |
30 |
Inj. fentanyl 0.5 µg/kg IV |